
Granus Pharmaceuticals Private Limited
About Granus Pharmaceuticals Private Limited
Data last updated:
Granus Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 14 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51507UP2016PTC084012. Its GSTIN is 09AAGCG4135R1Z1 (Uttar Pradesh).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arvind Kumar Srivastava and Chandrark Pandey.
Its last annual general meeting (AGM) was held on 29 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2/307 Vishal Khand Gomtinagar, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2025, the company reported a revenue of ₹27 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.49 Lakh (net margin 5.5%) and EBITDA of ₹2.01 Lakh (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Granus Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address2/307 Vishal Khand Gomtinagar, Lucknow, Uttar Pradesh, India – 226010
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Granus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Granus Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Granus Pharmaceuticals Private Limited, buy the company report.
Financials of Granus Pharmaceuticals Private Limited
FY 2025 filings availableGranus Pharmaceuticals Private Limited reported revenue of ₹27 Lakh (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 5.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Granus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Granus Pharmaceuticals Private Limited
Granus Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Srivastava Also directs: Recyclo Biomedical Waste Products LLP | Director | 14 Jun 2016 | 10 Years 5 Months | Current |
| Chandrark Pandey | Director | 14 Jun 2016 | 10 Years 5 Months | Current |
Peer comparison
Granus Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stericure Pharmaceuticals Private Limited | ₹27.55 Lakh (FY 2021) | 1181.0% | Puducherry, India | |||
| Granus Pharmaceuticals Private Limitedthis company | ₹27 Lakh (FY 2025) | ₹1.49 Lakh | 5.5% | -4.0% | Lucknow, Uttar Pradesh, India | |
| Clarshen Pharmaceuticals Private Limited | ₹26.96 Lakh (FY 2025) | 845.0% | Patna, Bihar, India | |||
| Glance Pharmaceuticals Private Limited | ₹26.84 Lakh (FY 2025) | 0.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Granus Pharmaceuticals Private Limited, buy the company report.
Auditor
Granus Pharmaceuticals Private Limited is audited by GUPTA S S K AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA S S K AND ASSOCIATES | FY 2017 | 009558C |
Shareholding
The shareholding of Granus Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Granus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Granus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Granus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Granus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCG4135R1Z1 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Granus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Granus Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Arvind Kumar Srivastava was appointed as Director on 14 Jun 2016.
Frequently asked questions
Granus Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 14 June 2016 (10+ years old) and is registered under CIN U51507UP2016PTC084012.
Granus Pharmaceuticals has 2 current directors:
- Arvind Kumar Srivastava - Director
- Chandrark Pandey - Director
The latest financial statements of Granus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 August 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Granus Pharmaceuticals is 09AAGCG4135R1Z1, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Granus Pharmaceuticals is U51507UP2016PTC084012. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Granus Pharmaceuticals was incorporated on 14 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Granus Pharmaceuticals by revenue are Stericure Pharmaceuticals Private Limited, Clarshen Pharmaceuticals Private Limited, Glance Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arvind Kumar Srivastava was appointed as Director on 14 Jun 2016. Chandrark Pandey was appointed as Director on 14 Jun 2016.
The registered office of Granus Pharmaceuticals is at 2307 Vishal Khand Gomtinagar, Lucknow, Uttar Pradesh, India – 226010.
Granus Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Granus Pharmaceuticals is compliant as of 22 July 2026. The company is actively filing with the Registrar of Companies.

